Clinical Research Directory
Browse clinical research sites, groups, and studies.
PPOS (Progestin Primed Ovarian Stimulation) and Corifollitropin Alfa (CFA) Cross-over Study
Sponsor: University Hospital, Ghent
Summary
P-CCROSS is a randomized, prospective monocentric phase 4 study with a crossover study design. The aim of the study is to compare patient satisfaction (by means of questionnaires) and treatment compliance with IVF treatment with CFA (corifollitropin alfa) and PPOS (Progestin-Primed Ovarian Stimulation) versus conventional IVF treatment with a recombinant FSH/GnRH antagonist. The study will also compare patients undergoing elective fertility preservation versus PGT-A (pre-implantation genetic testing for aneuploidy) patients.The study will have a crossover design so that patients will receive both forms of treatment. The investigators will also compare the endocrine profile and ovarian response of CFA/PPOS versus rFSH/GnRH ovarian stimulation cycles.
Official title: PPOS and CFA for Elective Freeze-all Ovarian Stimulation Cycles: a Prospective Cross-over Study
Key Details
Gender
FEMALE
Age Range
18 Years - 40 Years
Study Type
INTERVENTIONAL
Enrollment
60
Start Date
2025-01-27
Completion Date
2027-12-31
Last Updated
2025-12-26
Healthy Volunteers
No
Interventions
Elonva®
Single injection
Puregon®
Multiple injections
Orgalutran®
Multiple injections
Gonapeptyl®
Double injection
Cerazette®
Oral tablet
Locations (1)
University Hospital Ghent
Ghent, Belgium